Literature for peptidase M01.001: aminopeptidase N

(References are filtered for relevance to Target. To remove the filter click here. See explanation.)

2013
1. Lai,A., Hosseini-Tabatabaei,A., Hartwell,R., Rahmani-Neishaboor,E., Kilani,R.T. and Ghahary,A.
   Topical application of aminopeptidase N-neutralizing antibody accelerates wound closure
   Mol Cell Biochem372, 95-100. PubMed  Europe PubMed DOI  T
2011
2. Wickstrom,M., Larsson,R., Nygren,P. and Gullbo,J.
   Aminopeptidase N (CD13) as a target for cancer chemotherapy
   Cancer Sci102, 501-508. PubMed  Europe PubMed DOI  V  T
2010
3. Haraguchi,N., Ishii,H., Mimori,K., Tanaka,F., Ohkuma,M., Kim,H.M., Akita,H., Takiuchi,D., Hatano,H., Nagano,H., Barnard,G.F., Doki,Y. and Mori,M.
   CD13 is a therapeutic target in human liver cancer stem cells
   J Clin Invest120, 3326-3339. PubMed  Europe PubMed DOI  T
2007
4. Thielitz,A., Reinhold,D., Vetter,R., Bank,U., Helmuth,M., Hartig,R., Wrenger,S., Wiswedel,I., Lendeckel,U., Kahne,T., Neubert,K., Faust,J., Zouboulis,C.C., Ansorge,S. and Gollnick,H.
   Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation
   J Invest Dermatol127, 1042-1051. PubMed  Europe PubMed DOI  T  I
2006
5. [YEAR:7-10-2006]Bauvois,B. and Dauzonne,D.
   Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects
   Med Res Rev26, 88-130. PubMed  Europe PubMed DOI  T  I
1996
6. Fujii,H., Nakajima,M., Aoyagi,T. and Tsuruo,T.
   Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors
   Biol Pharm Bull19, 6-10. PubMed  Europe PubMed  T  I